Showing results (51-60 of 887) with videos related to
Sort By:
Pageof 89
Kidney International|February 9, 2005
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indicationsGunter Wolf, Eberhard RitzClinical Kidney Journal|February 24, 2023
From WEDA to EDTA to ERA: 60 years of supporting European nephrology and countingChristoph WannerSeminars in Nephrology|January 6, 2009
Prevention of cardiovascular disease in chronic kidney disease patientsChristoph WannerThe American Journal of Cardiology|June 14, 2017
EMPA-REG OUTCOME: The Nephrologist's Point of ViewChristoph WannerThe American Journal of Medicine|May 21, 2017
EMPA-REG OUTCOME: The Nephrologist's Point of ViewChristoph WannerClinical Therapeutics|December 6, 2007
Fabry disease model: a rational approach to the management of Fabry diseaseChristoph WannerCurrent Opinion in Nephrology and Hypertension|August 21, 2002
The renal risks of smoking: an updateStephan R Orth, Eberhard RitzAdvances in Renal Replacement Therapy|August 31, 2002
Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patientsJoseph A Coladonato, Eberhard RitzCurrent Hypertension Reports|January 8, 2008
Do beta-blockers combined with RAS inhibitors make sense after all to protect against renal injury?Eberhard Ritz, Lars Christian RumpJournal of the American Society of Nephrology : JASN|June 9, 2012
Sodium chloride intake: is lower always better?Hiddo Lambers Heerspink, Eberhard RitzPageof 89